Skip to main content
Clinical Trials/IRCT20090808002306N6
IRCT20090808002306N6
Recruiting
Phase 2

Clinical study of the effect of oral products of three plants: licorice (Glycyrrhiza glabra), fragrant violet (Viola adorata) and tarpaulin (Operculina turpethum) as an add-on on the intervals and severity of moderate chronic asthma attacks in children and adolescents 6 to 18 years

Esfahan University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
moderate persistent asthma.
Sponsor
Esfahan University of Medical Sciences
Enrollment
40
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All patients between 6 and 18 years old with chronic asthma in children and adolescents with moderate severity according to the Nelson Pediatrics textbook published in 2018 (page 202\)
  • Do not use other drugs at the same time and outside the official treatment protocol that is effective on the disease.
  • No possible history of underlying cardiovascular, renal, hepatic and biliary tract diseases

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials